GlassScriptPhysician profile
Barbara L Estes
NPI 1508998816
$417.63
in general payments reported to CMS, 2019-2025
13 companies · $112 in 2025
The $112 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $101 · 2021: $126 · 2023: $78.51 · 2025: $112.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $190.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $190.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Therapeuticsmd, INC. | $126.41 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $56.99 | 2023-2025 | |
| Abbvie INC. | $45.02 | 2019 | |
| Baxter Healthcare | $30.35 | 2025 | Perclot |
| Merck Sharp & Dohme LLC | $30.17 | 2019 | |
| Sumitomo Pharma America, INC. | $21.61 | 2023 | Myfembree |
| Hologic Sales and Service, LLC | $21.09 | 2025 | Aptima |
| Astellas Pharma US INC | $18.09 | 2025 | Veozah |
| Novo Nordisk INC | $14.85 | 2023 | Wegovy |
| Medtronic, INC. | $13.99 | 2025 | Ligasure |
| Pfizer INC. | $13.36 | 2019 | |
| Minerva Surgical, INC | $13.27 | 2023 | |
| Shire North American Group INC | $12.43 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Barbara Estes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.